Table 4.
Study | Study design | Study dates | Country | Follow-up | Number of participants | Number with repeat PK | Funding source and declarations of interest |
---|---|---|---|---|---|---|---|
| |||||||
Ghaffariyeh 2011 | Retrospective case series of the Fyodorov-Zuev KPro | 2003-2007 | Iran (Dr. Khodadoust Eye Hospital) | Mean 52 months (range 28 to 84 months) | 10 (10 eyes) | 10/10 (100%) | “None of the authors have any financial or proprietary interest in any material or method mentioned.” |
| |||||||
Hille 2006 | Retrospective case series the OOKP | 1993-2004 | Germany (University of Saarland) | Median 2.9 years | 25 (25 eyes) | 18/25 (72%) | NR |
Study | Number with BCVA ≥ 20/100 | Other visual acuity outcomes | Number of graft failures | Number of device extrusions | ||||
---|---|---|---|---|---|---|---|---|
|
|
|||||||
1 year | 2 years | 5 years | 1 year | 2 years | 5 years | |||
| ||||||||
Ghaffariyeh 2011 | 8/10 | 8/10 | 2/4 | “Patients retained BUVA of 20/200-20/50 in 50%, 20/60-20/100 in 30%, 20/200 in 10% and 20/400 in 10% of cases. Overall, 90% had 1 year postoperative vision of 20/200 or better. Eyes had 20/200 or better in 70% of cases at the last follow-up (average 52 months).” | 1/10 (10%) | 2/10 (20%) | 3/10 (30%) at 3 years; failure rate 30% during follow-up | 3/10 (30%) during follow-up |
| ||||||||
Hille 2006 | 11/20 (55%) | 7/14 (50%) | 2/5 (40%) | 79% achieved ambulatory vision of 20/400 at last follow up | NR | NR | NR | None reported |
BCVA: best-corrected visual acuity
BUVA: best-uncorrected visual acuity
OOKP: osteo-odonto-keratoprosthesis
NR: not reported
PK: penetrating keratoplasty